33 results on '"MCARTHUR, GRANT A."'
Search Results
2. An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic
3. Co‐targeting bromodomain and extra‐terminal proteins andMCL1induces synergistic cell death in melanoma
4. Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti‐PD‐1 therapy
5. Bevacizumab as a steroid-sparing agent during immunotherapy for melanoma brain metastases: A case series
6. Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance
7. Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting
8. Concordance of somatic mutational profile in multiple primary melanomas
9. Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance
10. Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib
11. Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death-1 monoclonal antibodies for advanced melanoma
12. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)
13. Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists
14. The state of melanoma: challenges and opportunities
15. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH‐MYCN neuroblastoma mouse model
16. Clinicopathological characteristics associated with BRAFK601E and BRAFL597 mutations in melanoma
17. The genomic landscape of phaeochromocytoma
18. Ubiquitous expression of thePik3ca H1047Rmutation promotes hypoglycemia, hypoinsulinemia, and organomegaly
19. Clinical and pathological associations of the activatingRAC1P29S mutation in primary cutaneous melanoma
20. Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151
21. Controversies in the management of gastrointestinal stromal tumors
22. Loss ofCDKN2Aexpression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
23. Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer
24. Impact of MET expression on outcome in BRAFV600E/Kadvanced melanoma
25. AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-MycB-cell lymphomain vivo
26. Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
27. BRAF, a target in melanoma
28. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure
29. Consensus approaches to best practice management of gastrointestinal stromal tumors
30. Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management*
31. MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation
32. Analysis of Myc/Max/Mad network members in adipogenesis: Inhibition of the proliferative burst and differentiation by ectopically expressed Mad1
33. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.